Ratings by Chardan (Andreas Argyrides)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/18/2026 | EyePoint Inc. | EYPT | Downgrade | Neutral (Buy) |
4.87 (4.58) |
-5.95% | Details | |
| 8/18/2026 | Rani Therapeutics | RANI | New Coverage | Buy (N/A) |
0.80 (0.86) |
7.5% | Details |
